Physician profile
George Macrinici
NPI 1659534030
$13,758.16
in general payments reported to CMS, 2019-2025
17 companies · $959 in 2025
The $959 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $1,942 · 2021: $1,975 · 2022: $3,707 · 2023: $1,733 · 2024: $2,371 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,064.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,544.58 | 2019-2025 | Proclaim, Eterna, Axium |
| Relievant Medsystems, INC. | $1,127.85 | 2019-2023 | Intracept |
| Spinal Simplicity, LLC | $998.22 | 2022-2025 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $457.21 | 2019-2020 | |
| Boston Scientific Corporation | $453.45 | 2020-2025 | Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $333.97 | 2021-2023 | Intellis Adaptivestim |
| Abbvie INC. | $210.63 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $116.91 | 2019 | |
| Allergan, INC. | $112.23 | 2019-2021 | |
| Nalu Medical, INC. | $107.44 | 2024-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $103.95 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $59.42 | 2019-2021 | |
| Saol Therapeutics INC. | $46.51 | 2019-2020 | |
| Valinor Pharma, LLC | $46.42 | 2025 | Movantik |
| Vertos Medical, INC. | $17.83 | 2024 | Mild Device Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $14.75 | 2022 | |
| Fidia Pharma USA INC. | $6.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Macrinici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.